Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

BMGL stock hub

Basel Medical Group Ltd has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BMGLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BMGL

In the news

Latest news · BMGL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-163.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-99.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BMGL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

SGD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002004489
Company name	Basel Medical Group Ltd
Country	Singapore
Country code	US
Cusip	G0864B103
Employees	82
Employees Change	50%
Employees Change Percent	156.3
Enterprise value	$11.7M
Exchange	NASDAQ
Financial currency	SGD
First seen	2026-05-09
Industry	Medical Care Facilities
IPO Date	2025-02-25
Isin	VGG0864B1031
Last refreshed	2026-05-10
Market cap	$14.3M
Market cap category	Nano-Cap
Price	$0.76
Price currency	USD
Rev Per Employee	108,748.52x
Sector	Healthcare
Sic	8011
Symbol	BMGL
Website	https://baselmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-58.58%
EV/Sales	1.31x
FCF yield	-82.69%
P/B ratio	3.34x
P/S ratio	1.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-18.85%
EBITDA Margin	-17.91%
Gross margin	21.18%
Gross Profit	$1.9M
Gross Profit Growth	-42.25%
Gross Profit Growth Q	-51.42%
Net Income	$-8.4M
Net Income Growth Years	0%
Pretax Margin	-97.35%
Profit Margin	-93.67%
Profit Per Employee	$-101,860
ROA	-7.65
ROCE	-25.13
ROE	-163.6
ROIC	-99.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-83.94%
EPS Growth Years	0
Revenue Growth	12.97x
Revenue Growth Q	27.3x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.65
Assets	$14.7M
Cash	$7.7M
Current Assets	$10.5M
Current Liabilities	$8M
Debt	$5.1M
Debt Equity	$1.2
Equity	$4.3M
Interest Coverage	-10.5
Liabilities	$10.4M
Long Term Assets	$4.2M
Long Term Liabilities	$2.4M
Net Cash	$2.6M
Net Cash By Market Cap	$18.12
Net Debt Equity	$-0.6
Tangible Book Value	$4.3M
Tangible Book Value Per Share	$0.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.31
Inventory Turnover	31.9
Net Working Capital	$-2.4M
Quick ratio	1.21
Working Capital	$2.5M
Working Capital Turnover	$1.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.61%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-83.92%
200-day SMA	1.16
50-day SMA	0.61
50-day SMA vs 200-day SMA	50under200
All Time High	9.4
All Time High Change	-91.93%
All Time High Date	2025-06-02
All Time Low	0.49
All Time Low Change	55.79%
All Time Low Date	2025-12-31
ATR	0.06
Beta1y	1.96
Beta2y	0.07
Ch YTD	54.9
High	0.78
High52	9.4
High52 Date	2025-06-02
High52ch	-91.93%
Low	0.69
Low52	0.49
Low52 Date	2025-12-31
Low52ch	55.79%
Ma50ch	24.43%
Premarket Change Percent	0.39
Premarket Price	$0.76
Price vs 200-day SMA	-34.34%
RSI	68.45
RSI Monthly	33.79
RSI Weekly	43.94
Sharpe ratio	0.53x
Sortino ratio	2.42
Total Return	-15.61%
Tr YTD	54.9
Tr1m	27.56%
Tr1w	35.54%
Tr3m	16.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-1.7M
Operating margin	-18.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,017,019%
Float Percent	32.03%
Net Borrowing	3,946,820.8
Shares Insiders	13.65%
Shares Institutions	0.7%
Shares Out	18,785,750
Shares Qo Q	31.21%
Shares Yo Y	15.61%
Short Float	1.85%
Short Ratio	3.37
Short Shares	0.59

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11.8M
Average Volume	23,409.85x
Bv Per Share	0.23
CAPEX	$-8.6M
Ch1m	27.56
Ch1w	35.54
Ch1y	-83.92
Ch3m	16.59
Ch6m	-46.17
Change	-0.13%
Change From Open	-2.57
Close	0.76
Days Gap	2.5
Depreciation Amortization	84,951.5
Dollar Volume	10,002.5
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-1.7M
EBITDA	$-1.6M
EPS	$-0.44
F Score	2
FCF	$-11.8M
FCF EV Yield	-100.98x
FCF Per Share	$-0.63
Financing CF	12,956,461
Fiscal Year End	June
Founded	2,001
Income Tax	$-327,791
Investing CF	-8,557,655
Ipr	-81.03
Iprfo	-81.89
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2025-11-17
Last Report Date	2025-06-30
Last Split Type	Never
Last10k Filing Date	2025-11-18
Ma150	0.88
Ma150ch	-13.84%
Ma20	0.62
Ma20ch	22.93%
Net CF	858,690
Next Earnings Date	2026-05-22
Open	0.78
Optionable	No
Position In Range	77.12
Post Close	0.76
Postmarket Change Percent	-3.82
Postmarket Price	$0.73
Ppne	4,212,127.4
Pre Close	0.76
Price Date	2026-05-08
Ptbv Ratio	3.34
Relative Volume	0.56x
Revenue	8,917,379x
Tax By Revenue	-3.68x
Tr6m	-46.17%
Volume	13,178.5
Z Score	4.4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BMGL pay a dividend?

Capital-return profile for this ticker.

Performance

BMGL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BMGL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.7%

Float: +32.0% of shares outstanding

Insider ownership

+13.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BMGL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.4

Neutral momentum band

Price vs 200-day MA

-34.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BMGL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BMGL stock rating?

Basel Medical Group Ltd is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BMGL analysis?

The full report lives at /stocks/BMGL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BMGL?

The latest report frames BMGL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BMGL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.